N-(4-amino-1-phenylpyrazol-3-yl)-5-[(4-imidazo[1,2-a]pyridin-3-yl-1,3-thiazol-2-yl)amino]thiophene-2-carboxamide
C24H18N8OS2 — CID 58163805
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-(4-amino-1-phenylpyrazol-3-yl)-5-[(4-imidazo[1,2-a]pyridin-3-yl-1,3-thiazol-2-yl)amino]thiophene-2-carboxamide
N-(4-amino-1-phenylpyrazol-3-yl)-5-[(4-imidazo[1,2-a]pyridin-3-yl-1,3-thiazol-2-yl)amino]thiophene-2-carboxamide (PubChem CID 58163805) has the molecular formula C24H18N8OS2 and a molecular weight of 498.60 g/mol. Its IUPAC name is N-(4-amino-1-phenylpyrazol-3-yl)-5-[(4-imidazo[1,2-a]pyridin-3-yl-1,3-thiazol-2-yl)amino]thiophene-2-carboxamide.
Molecular Properties
| Compound Name | N-(4-amino-1-phenylpyrazol-3-yl)-5-[(4-imidazo[1,2-a]pyridin-3-yl-1,3-thiazol-2-yl)amino]thiophene-2-carboxamide |
|---|---|
| PubChem CID | 58163805 |
| Molecular Formula | C24H18N8OS2 |
| Molecular Weight | 498.60 g/mol |
| Exact Mass | 498.10 |
| IUPAC Name | N-(4-amino-1-phenylpyrazol-3-yl)-5-[(4-imidazo[1,2-a]pyridin-3-yl-1,3-thiazol-2-yl)amino]thiophene-2-carboxamide |
| SMILES | Nc1cn(-c2ccccc2)nc1NC(=O)c1ccc(Nc2nc(-c3cnc4ccccn34)cs2)s1 |
| InChI | InChI=1S/C24H18N8OS2/c25-16-13-32(15-6-2-1-3-7-15)30-22(16)29-23(33)19-9-10-21(35-19)28-24-27-17(14-34-24)18-12-26-20-8-4-5-11-31(18)20/h1-14H,25H2,(H,27,28)(H,29,30,33) |
| InChIKey | KPBCIVVSEWCVGF-UHFFFAOYSA-N |
| XLogP | 5.28 |
| TPSA | 115.16 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 498.60 |
| LogP ≤ 5 | 5.28 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 10 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 58163805 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.